ClariMedClariMed
Recherchen nahtlos fortsetzen
30 Sek mit Email - kein Passwort, kein Formular. Ihr Verlauf bleibt auf jedem Gerät.

Verlauf

Keine Anfragen

IDSA2024EN

IDSA: Antimicrobial Resistance (AMR) Guidance

Zusammenfassung

Last updated December 31, 2023, and posted online at https://www.idsociety.org/practice-guideline/amr- guidance/. Please check website for most updated version of this guidance. 1 Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections Pranita D. Tamma, 1 Emily L. Heil 2 , Julie Ann Justo 3 , Amy J. Mathers 4 , Michael J. Satlin 5 , & Robert A. Bonomo, 6 Affiliations 1 Department of Pediatrics, Johns Hopkins Univ

Kerninformationen

kground: The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections. This guidance document focuses on infections caused by extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), AmpC β- ...
ed periodically. The most current version of this document, including date of publication, is available at www.idsociety.org/practice-guideline/amr-guidance/. Last updated December 31, 2023, and posted online at https://www.idsociety.org/practice-guideline/amr- guidance/. Please check website fo...
y of these pathogens have been designated urgent or serious threats by the CDC 2 . Each pathogen causes a wide range of infections that are encountered in United States hospitals of all sizes, and that carry with them significant morbidity and mortality. Guidance is presented in the form of answe...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien